The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Off-body Wearable Injectors Market Research Report 2025

Global Off-body Wearable Injectors Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1618132

No of Pages : 99

Ask Your Query

The global Off-body Wearable Injectors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Off-body Wearable Injectors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Off-body Wearable Injectors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Off-body Wearable Injectors include Becton, Dickinson and Company, Medtronic, Johnson & Johnson, Insulet Corporation, Unilife Corporation, Enable Injections, SteadyMed, Ypsomed Group and West Pharmaceutical Services, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Off-body Wearable Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Off-body Wearable Injectors.

Report Scope

The Off-body Wearable Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Off-body Wearable Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Off-body Wearable Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company(Partial List)

  •     Becton, Dickinson and Company
  •     Medtronic
  •     Johnson & Johnson
  •     Insulet Corporation
  •     Unilife Corporation
  •     Enable Injections
  •     SteadyMed
  •     Ypsomed Group
  •     West Pharmaceutical Services
  •     Unilife
  •     CeQur
  •     Sensile Medical
  •     Roche
  •     ScPharmaceuticals
  •     SteadyMed

Segment by Type

  •     Electronical Injectors
  •     Mechanical Injectors
  •     Others

Segment by Application

  •     Immuno-oncology
  •     Diabetes
  •     Cardiovascular Diseases
  •     Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Off-body Wearable Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Off-body Wearable Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

1 Off-body Wearable Injectors Market Overview
    1.1 Product Overview and Scope of Off-body Wearable Injectors
    1.2 Off-body Wearable Injectors Segment by Type
        1.2.1 Global Off-body Wearable Injectors Market Value Comparison by Type (2024-2030)
        1.2.2 Electronical Injectors
        1.2.3 Mechanical Injectors
        1.2.4 Others
    1.3 Off-body Wearable Injectors Segment by Application
        1.3.1 Global Off-body Wearable Injectors Market Value by Application: (2024-2030)
        1.3.2 Immuno-oncology
        1.3.3 Diabetes
        1.3.4 Cardiovascular Diseases
        1.3.5 Other
    1.4 Global Off-body Wearable Injectors Market Size Estimates and Forecasts
        1.4.1 Global Off-body Wearable Injectors Revenue 2019-2030
        1.4.2 Global Off-body Wearable Injectors Sales 2019-2030
        1.4.3 Global Off-body Wearable Injectors Market Average Price (2019-2030)
    1.5 Assumptions and Limitations

 2 Off-body Wearable Injectors Market Competition by Manufacturers
    2.1 Global Off-body Wearable Injectors Sales Market Share by Manufacturers (2019-2024)
    2.2 Global Off-body Wearable Injectors Revenue Market Share by Manufacturers (2019-2024)
    2.3 Global Off-body Wearable Injectors Average Price by Manufacturers (2019-2024)
    2.4 Global Off-body Wearable Injectors Industry Ranking 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Off-body Wearable Injectors, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Off-body Wearable Injectors, Product Type & Application
    2.7 Off-body Wearable Injectors Market Competitive Situation and Trends
        2.7.1 Off-body Wearable Injectors Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Off-body Wearable Injectors Players Market Share by Revenue
        2.7.3 Global Off-body Wearable Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Off-body Wearable Injectors Retrospective Market Scenario by Region
    3.1 Global Off-body Wearable Injectors Market Size by Region: 2019 Versus 2023 Versus 2030
    3.2 Global Off-body Wearable Injectors Global Off-body Wearable Injectors Sales by Region: 2019-2030
        3.2.1 Global Off-body Wearable Injectors Sales by Region: 2019-2024
        3.2.2 Global Off-body Wearable Injectors Sales by Region: 2025-2030
    3.3 Global Off-body Wearable Injectors Global Off-body Wearable Injectors Revenue by Region: 2019-2030
        3.3.1 Global Off-body Wearable Injectors Revenue by Region: 2019-2024
        3.3.2 Global Off-body Wearable Injectors Revenue by Region: 2025-2030
    3.4 North America Off-body Wearable Injectors Market Facts & Figures by Country
        3.4.1 North America Off-body Wearable Injectors Market Size by Country: 2019 VS 2023 VS 2030
        3.4.2 North America Off-body Wearable Injectors Sales by Country (2019-2030)
        3.4.3 North America Off-body Wearable Injectors Revenue by Country (2019-2030)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Off-body Wearable Injectors Market Facts & Figures by Country
        3.5.1 Europe Off-body Wearable Injectors Market Size by Country: 2019 VS 2023 VS 2030
        3.5.2 Europe Off-body Wearable Injectors Sales by Country (2019-2030)
        3.5.3 Europe Off-body Wearable Injectors Revenue by Country (2019-2030)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Off-body Wearable Injectors Market Facts & Figures by Country
        3.6.1 Asia Pacific Off-body Wearable Injectors Market Size by Country: 2019 VS 2023 VS 2030
        3.6.2 Asia Pacific Off-body Wearable Injectors Sales by Country (2019-2030)
        3.6.3 Asia Pacific Off-body Wearable Injectors Revenue by Country (2019-2030)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
    3.7 Latin America Off-body Wearable Injectors Market Facts & Figures by Country
        3.7.1 Latin America Off-body Wearable Injectors Market Size by Country: 2019 VS 2023 VS 2030
        3.7.2 Latin America Off-body Wearable Injectors Sales by Country (2019-2030)
        3.7.3 Latin America Off-body Wearable Injectors Revenue by Country (2019-2030)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Off-body Wearable Injectors Market Facts & Figures by Country
        3.8.1 Middle East and Africa Off-body Wearable Injectors Market Size by Country: 2019 VS 2023 VS 2030
        3.8.2 Middle East and Africa Off-body Wearable Injectors Sales by Country (2019-2030)
        3.8.3 Middle East and Africa Off-body Wearable Injectors Revenue by Country (2019-2030)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Off-body Wearable Injectors Sales by Type (2019-2030)
        4.1.1 Global Off-body Wearable Injectors Sales by Type (2019-2024)
        4.1.2 Global Off-body Wearable Injectors Sales by Type (2025-2030)
        4.1.3 Global Off-body Wearable Injectors Sales Market Share by Type (2019-2030)
    4.2 Global Off-body Wearable Injectors Revenue by Type (2019-2030)
        4.2.1 Global Off-body Wearable Injectors Revenue by Type (2019-2024)
        4.2.2 Global Off-body Wearable Injectors Revenue by Type (2025-2030)
        4.2.3 Global Off-body Wearable Injectors Revenue Market Share by Type (2019-2030)
    4.3 Global Off-body Wearable Injectors Price by Type (2019-2030)

 5 Segment by Application
    5.1 Global Off-body Wearable Injectors Sales by Application (2019-2030)
        5.1.1 Global Off-body Wearable Injectors Sales by Application (2019-2024)
        5.1.2 Global Off-body Wearable Injectors Sales by Application (2025-2030)
        5.1.3 Global Off-body Wearable Injectors Sales Market Share by Application (2019-2030)
    5.2 Global Off-body Wearable Injectors Revenue by Application (2019-2030)
        5.2.1 Global Off-body Wearable Injectors Revenue by Application (2019-2024)
        5.2.2 Global Off-body Wearable Injectors Revenue by Application (2025-2030)
        5.2.3 Global Off-body Wearable Injectors Revenue Market Share by Application (2019-2030)
    5.3 Global Off-body Wearable Injectors Price by Application (2019-2030)

 6 Key Companies Profiled
    6.1 Becton, Dickinson and Company
        6.1.1 Becton, Dickinson and Company Corporation Information
        6.1.2 Becton, Dickinson and Company Description and Business Overview
        6.1.3 Becton, Dickinson and Company Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.1.4 Becton, Dickinson and Company Off-body Wearable Injectors Product Portfolio
        6.1.5 Becton, Dickinson and Company Recent Developments/Updates
    6.2 Medtronic
        6.2.1 Medtronic Corporation Information
        6.2.2 Medtronic Description and Business Overview
        6.2.3 Medtronic Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.2.4 Medtronic Off-body Wearable Injectors Product Portfolio
        6.2.5 Medtronic Recent Developments/Updates
    6.3 Johnson & Johnson
        6.3.1 Johnson & Johnson Corporation Information
        6.3.2 Johnson & Johnson Description and Business Overview
        6.3.3 Johnson & Johnson Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.3.4 Johnson & Johnson Off-body Wearable Injectors Product Portfolio
        6.3.5 Johnson & Johnson Recent Developments/Updates
    6.4 Insulet Corporation
        6.4.1 Insulet Corporation Corporation Information
        6.4.2 Insulet Corporation Description and Business Overview
        6.4.3 Insulet Corporation Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 Insulet Corporation Off-body Wearable Injectors Product Portfolio
        6.4.5 Insulet Corporation Recent Developments/Updates
    6.5 Unilife Corporation
        6.5.1 Unilife Corporation Corporation Information
        6.5.2 Unilife Corporation Description and Business Overview
        6.5.3 Unilife Corporation Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.5.4 Unilife Corporation Off-body Wearable Injectors Product Portfolio
        6.5.5 Unilife Corporation Recent Developments/Updates
    6.6 Enable Injections
        6.6.1 Enable Injections Corporation Information
        6.6.2 Enable Injections Description and Business Overview
        6.6.3 Enable Injections Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.6.4 Enable Injections Off-body Wearable Injectors Product Portfolio
        6.6.5 Enable Injections Recent Developments/Updates
    6.7 SteadyMed
        6.6.1 SteadyMed Corporation Information
        6.6.2 SteadyMed Description and Business Overview
        6.6.3 SteadyMed Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 SteadyMed Off-body Wearable Injectors Product Portfolio
        6.7.5 SteadyMed Recent Developments/Updates
    6.8 Ypsomed Group
        6.8.1 Ypsomed Group Corporation Information
        6.8.2 Ypsomed Group Description and Business Overview
        6.8.3 Ypsomed Group Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.8.4 Ypsomed Group Off-body Wearable Injectors Product Portfolio
        6.8.5 Ypsomed Group Recent Developments/Updates
    6.9 West Pharmaceutical Services
        6.9.1 West Pharmaceutical Services Corporation Information
        6.9.2 West Pharmaceutical Services Description and Business Overview
        6.9.3 West Pharmaceutical Services Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.9.4 West Pharmaceutical Services Off-body Wearable Injectors Product Portfolio
        6.9.5 West Pharmaceutical Services Recent Developments/Updates
    6.10 Unilife
        6.10.1 Unilife Corporation Information
        6.10.2 Unilife Description and Business Overview
        6.10.3 Unilife Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.10.4 Unilife Off-body Wearable Injectors Product Portfolio
        6.10.5 Unilife Recent Developments/Updates
    6.11 CeQur
        6.11.1 CeQur Corporation Information
        6.11.2 CeQur Off-body Wearable Injectors Description and Business Overview
        6.11.3 CeQur Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.11.4 CeQur Off-body Wearable Injectors Product Portfolio
        6.11.5 CeQur Recent Developments/Updates
    6.12 Sensile Medical
        6.12.1 Sensile Medical Corporation Information
        6.12.2 Sensile Medical Off-body Wearable Injectors Description and Business Overview
        6.12.3 Sensile Medical Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.12.4 Sensile Medical Off-body Wearable Injectors Product Portfolio
        6.12.5 Sensile Medical Recent Developments/Updates
    6.13 Roche
        6.13.1 Roche Corporation Information
        6.13.2 Roche Off-body Wearable Injectors Description and Business Overview
        6.13.3 Roche Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.13.4 Roche Off-body Wearable Injectors Product Portfolio
        6.13.5 Roche Recent Developments/Updates
    6.14 ScPharmaceuticals
        6.14.1 ScPharmaceuticals Corporation Information
        6.14.2 ScPharmaceuticals Off-body Wearable Injectors Description and Business Overview
        6.14.3 ScPharmaceuticals Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.14.4 ScPharmaceuticals Off-body Wearable Injectors Product Portfolio
        6.14.5 ScPharmaceuticals Recent Developments/Updates
    6.15 SteadyMed
        6.15.1 SteadyMed Corporation Information
        6.15.2 SteadyMed Off-body Wearable Injectors Description and Business Overview
        6.15.3 SteadyMed Off-body Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
        6.15.4 SteadyMed Off-body Wearable Injectors Product Portfolio
        6.15.5 SteadyMed Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Off-body Wearable Injectors Industry Chain Analysis
    7.2 Off-body Wearable Injectors Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Off-body Wearable Injectors Production Mode & Process
    7.4 Off-body Wearable Injectors Sales and Marketing
        7.4.1 Off-body Wearable Injectors Sales Channels
        7.4.2 Off-body Wearable Injectors Distributors
    7.5 Off-body Wearable Injectors Customers

 8 Off-body Wearable Injectors Market Dynamics
    8.1 Off-body Wearable Injectors Industry Trends
    8.2 Off-body Wearable Injectors Market Drivers
    8.3 Off-body Wearable Injectors Market Challenges
    8.4 Off-body Wearable Injectors Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock